Sg3 Management, LLC Ionis Pharmaceuticals Inc Call Options Transaction History

Sg3 Management, LLC

8 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q2 2022 Aug 15, 2022	SELL	$31.71 - $43.0 $88,788 - $120,400	-2,800 Reduced 20.29%	11,000 $407,000
Q1 2022 May 16, 2022	SELL	$29.88 - $37.04 $35,856 - $44,448	-1,200 Reduced 8.0%	13,800 $511,000
Q4 2021 Feb 15, 2022	BUY	$25.61 - $35.1 $130,611 - $179,010	5,100 Added 51.52%	15,000 $456,000
Q3 2021 Nov 15, 2021	SELL	$33.54 - $40.55 $707,694 - $855,604	-21,100 Reduced 68.06%	9,900 $332,000
Q2 2021 Aug 16, 2021	SELL	$34.54 - $47.25 $977,482 - $1.34 Million	-28,300 Reduced 47.72%	31,000 $1.24 Million
Q1 2021 May 17, 2021	SELL	$42.51 - $63.78 $454,857 - $682,446	-10,700 Reduced 15.29%	59,300 $2.67 Million
Q4 2020 Feb 16, 2021	BUY	$45.3 - $60.27 $1.81 Million - $2.41 Million	40,000 Added 133.33%	70,000 $3.96 Million
Q3 2020 Nov 13, 2020	BUY	$47.45 - $62.95 $1.42 Million - $1.89 Million	30,000 New	30,000 $1.42 Million

402

136M

862K

582K

Ticker IONS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 141,940,992
Market Cap $5.19B
Description
Ionis Pharmaceuticals, Inc. discovers and develops RNA-targeted therapeutics in the United States. The company offers SPINRAZA for spinal muscular atrophy (SMA) in pediatric and adult patients; TEGSEDI, an injection for the treatment of polyneuropathy of hereditary transthyretin-mediated amyloidosis in adults; and WAYLIVRA, a treatment for famil...

Get notified when there are updates to the investment portfolio of Sg3 Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Sg3 Management, LLC with notifications on news.